AUPR064300A0 - Anti-tumour compounds - Google Patents
Anti-tumour compoundsInfo
- Publication number
- AUPR064300A0 AUPR064300A0 AUPR0643A AUPR064300A AUPR064300A0 AU PR064300 A0 AUPR064300 A0 AU PR064300A0 AU PR0643 A AUPR0643 A AU PR0643A AU PR064300 A AUPR064300 A AU PR064300A AU PR064300 A0 AUPR064300 A0 AU PR064300A0
- Authority
- AU
- Australia
- Prior art keywords
- tumour compounds
- tumour
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/08—Aza-anthracenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR0643A AUPR064300A0 (en) | 2000-10-09 | 2000-10-09 | Anti-tumour compounds |
PCT/AU2001/001265 WO2002030906A1 (en) | 2000-10-09 | 2001-10-09 | Anti-tumour compounds |
AU2001295251A AU2001295251A1 (en) | 2000-10-09 | 2001-10-09 | Anti-tumour compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR0643A AUPR064300A0 (en) | 2000-10-09 | 2000-10-09 | Anti-tumour compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPR064300A0 true AUPR064300A0 (en) | 2000-11-02 |
Family
ID=3824701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPR0643A Abandoned AUPR064300A0 (en) | 2000-10-09 | 2000-10-09 | Anti-tumour compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPR064300A0 (en) |
WO (1) | WO2002030906A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3842100A (en) * | 1972-12-21 | 1974-10-15 | Richardson Merrell Inc | Benzanthracene derivatives |
JPH07160021A (en) * | 1993-12-03 | 1995-06-23 | Konica Corp | Electrophotograpic photoreceptor |
US5861398A (en) * | 1996-08-26 | 1999-01-19 | Alanex Corporation | Benzoperimidine-carboxylic acids and derivatives thereof |
-
2000
- 2000-10-09 AU AUPR0643A patent/AUPR064300A0/en not_active Abandoned
-
2001
- 2001-10-09 WO PCT/AU2001/001265 patent/WO2002030906A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002030906A1 (en) | 2002-04-18 |
WO2002030906B1 (en) | 2002-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002218266A1 (en) | Novel indanylidene compounds | |
AU2002225730A1 (en) | Compounds | |
AU2002349297A1 (en) | Statin-like compounds | |
AU2001268475A1 (en) | 7-phenyl-substituted tetracycline compounds | |
AU2001292518A1 (en) | Novel compounds | |
AU2001266345A1 (en) | Five-membered-ring compound | |
AUPQ661800A0 (en) | Insulin-potentiating compounds | |
AU2001239765A1 (en) | Novel compounds | |
AU2001246998A1 (en) | Novel compounds | |
AU2001253362A1 (en) | Novel compounds | |
AU2002231077A1 (en) | Novel compounds | |
AU2001256964A1 (en) | Novel compounds | |
AU2000254942A1 (en) | 7-phenyl-substituted tetracycline compounds | |
AU2002225724A1 (en) | Motilide compounds | |
AU2002220684A1 (en) | Fap-alpha-activated anti-tumor compounds | |
AU2002217285A1 (en) | Compounds | |
AU2001230689A1 (en) | Novel compounds | |
AU2002216060A1 (en) | Novel compounds | |
AU2002221923A1 (en) | Novel compounds | |
AU2001276890A1 (en) | Novel compounds | |
AU2001230585A1 (en) | Pyrrolopyridazine compound | |
AU2001237533A1 (en) | Novel p-gp-inhibiting compounds | |
AU2001258760A1 (en) | Novel thiophenamide compounds | |
AUPR920301A0 (en) | Neurologically-active compounds | |
AU2002216043A1 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 9525101 Country of ref document: AU |